文献速递产科母胎医学

中孕期阶段筛查预测小于胎龄儿

Second-trimester contingent screening for small-for-gestational-age neonate.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-12

研究发现联合模型预测优于单独母体风险因素,且阶段筛查策略可在减少检测比例的同时达到相似检出率和假阳性率。

要点

  • 联合母体风险因素、EFW、UtA-PI和PlGF可有效预测中孕期SGA。
  • PlGF对预测出生体重<第3百分位且<30周分娩的SGA额外价值最大。
  • 阶段筛查可仅对部分人群检测UtA-PI和PlGF达到相似检出率。

核心结论

  • 联合母体风险因素、EFW、UtA-PI和PlGF可有效预测中孕期SGA。
  • 血清PlGF在全面评估母体风险因素和生物物理标志物后,对预测出生体重<第3百分位且<30周分娩的SGA有用。
  • 采用阶段筛查策略可达到相似的检出率和假阳性率。

研究设计与样本

  • 使用竞争风险模型预测SGA,拟合折叠平面回归模型描述PlGF似然。
  • 比较母体风险因素单独筛查与联合EFW、UtA-PI和PlGF筛查的预测效能。

主要发现

  • 随着早产程度增加、小于程度加重及合并子痫前期,SGA预测改善。
  • 联合母体风险因素、EFW、UtA-PI和PlGF较单独母体风险因素在所有 examined 出生体重和分娩孕周切点均显著改善预测。
  • 母体风险因素联合血清PlGF较单独母体风险因素改善SGA预测,但加入EFW和UtA-PI后PlGF的增量改善减小。

关键数值与推荐

  • 筛查出生体重<第10百分位且<37周分娩的SGA,一线用母体风险因素和EFW,对80%人群检测UtA-PI和PlGF可达总体假阳性率50%时90%检出率。
  • 筛查出生体重<第10百分位且<30周分娩的SGA,对70%人群检测UtA-PI和PlGF可达总体假阳性率14%时90%检出率。
  • 筛查出生体重<第3百分位且<30周分娩的SGA,一线用母体风险因素、EFW和UtA-PI,对50%人群检测PlGF可将假阳性率降至约10%同时检出率90%。

临床怎么用

  • 中孕期可联合母体风险因素、EFW、UtA-PI和PlGF预测SGA。
  • 可采用阶段筛查策略,仅对部分人群检测UtA-PI和PlGF以减少检测负担。
  • PlGF尤其适用于全面评估后预测出生体重<第3百分位且<30周分娩的SGA。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: First, to investigate the additive value of second-trimester placental growth factor (PlGF) for the prediction of a small-for-gestational-age (SGA) neonate. Second, to examine second-trimester contingent screening strategies. METHODS: This was a prospective observational study in women with singleton pregnancy undergoing routine ultrasound examination at 19-24 weeks' gestation. We used the competing-risks model for prediction of SGA. The parameters for the prior model and the likelihoods for estimated fetal weight (EFW) and uterine artery pulsatility index (UtA-PI) were those presented in previous studies. A folded-plane regression model was fitted in the dataset of this study to describe the likelihood of PlGF. We compared the prediction of screening by maternal risk factors against the prediction provided by a combination of maternal risk factors, EFW, UtA-PI and PlGF. We also examined the additive value of PlGF in a policy that uses maternal risk factors, EFW and UtA-PI. RESULTS: The study population included 40 241 singleton pregnancies. Overall, the prediction of SGA improved with increasing degree of prematurity, with increasing severity of smallness and in the presence of coexisting pre-eclampsia. The combination of maternal risk factors, EFW, UtA-PI and PlGF improved significantly the prediction provided by maternal risk factors alone for all the examined cut-offs of birth weight and gestational age at delivery. Screening by a combination of maternal risk factors and serum PlGF improved the prediction of SGA when compared to screening by maternal risk factors alone. However, the incremental improvement in prediction was decreased when PlGF was added to screening by a combination of maternal risk factors, EFW and UtA-PI. If first-line screening for a SGA neonate with birth weight < 10th percentile delivered at < 37 weeks' gestation was by maternal risk factors and EFW, the same detection rate of 90%, at an overall false-positive rate (FPR) of 50%, as that achieved by screening with maternal risk factors, EFW, UtA-PI and PlGF in the whole population can be achieved by reserving measurements of UtA-PI and PlGF for only 80% of the population. Similarly, in screening for a SGA neonate with birth weight < 10th percentile delivered at < 30 weeks, the same detection rate of 90%, at an overall FPR of 14%, as that achieved by screening with maternal risk factors, EFW, UtA-PI and PlGF in the whole population can be achieved by reserving measurements of UtA-PI and PlGF for only 70% of the population. The additive value of PlGF in reducing the FPR to about 10% with a simultaneous detection rate of 90% for a SGA neonate with birth weight < 3rd percentile born < 30 weeks, is gained by measuring PlGF in only 50% of the population when first-line screening is by maternal factors, EFW and UtA-PI. CONCLUSIONS: The combination of maternal risk factors, EFW, UtA-PI and PlGF provides effective second-trimester prediction of SGA. Serum PlGF is useful for predicting a SGA neonate with birth weight < 3rd percentile born < 30 weeks after an inclusive assessment by maternal risk factors and biophysical markers. Similar detection rates and FPRs can be achieved by application of contingent screening strategies. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Nowacka U, Papastefanou I, Bouariu A, et al. Second-trimester contingent screening for small-for-gestational-age neonate. Ultrasound Obstet Gynecol. 2022. PMID: 34214232. doi:10.1002/uog.23730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。